| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.05e-04 | 118 | 79 | 5 | GO:0003774 | |
| GeneOntologyCellularComponent | myosin II complex | 3.61e-06 | 28 | 79 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | symmetric synapse | 1.45e-05 | 13 | 79 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | muscle myosin complex | 2.81e-05 | 16 | 79 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 7.34e-05 | 59 | 79 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 8.42e-05 | 4 | 79 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | myosin filament | 1.13e-04 | 25 | 79 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | inner dynein arm | 6.22e-04 | 10 | 79 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | vacuolar membrane | 6.54e-04 | 507 | 79 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 9.08e-04 | 12 | 79 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | azurophil granule membrane | 1.45e-03 | 59 | 79 | 3 | GO:0035577 | |
| Domain | NLGN4 | 1.72e-05 | 2 | 78 | 2 | IPR030025 | |
| Domain | Myosin_head_motor_dom | 1.87e-05 | 38 | 78 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.87e-05 | 38 | 78 | 4 | PS51456 | |
| Domain | Myosin_head | 1.87e-05 | 38 | 78 | 4 | PF00063 | |
| Domain | MYSc | 1.87e-05 | 38 | 78 | 4 | SM00242 | |
| Domain | Myosin_N | 3.08e-05 | 15 | 78 | 3 | PF02736 | |
| Domain | Myosin_N | 3.08e-05 | 15 | 78 | 3 | IPR004009 | |
| Domain | IQ_motif_EF-hand-BS | 3.72e-05 | 90 | 78 | 5 | IPR000048 | |
| Domain | IQ | 4.35e-05 | 93 | 78 | 5 | PS50096 | |
| Domain | Myosin_tail_1 | 5.47e-05 | 18 | 78 | 3 | PF01576 | |
| Domain | Myosin_tail | 5.47e-05 | 18 | 78 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 6.47e-05 | 19 | 78 | 3 | IPR027401 | |
| Domain | - | 6.47e-05 | 19 | 78 | 3 | 4.10.270.10 | |
| Domain | Nlgn | 1.71e-04 | 5 | 78 | 2 | IPR000460 | |
| Domain | Somatomedin_B_chordata | 1.71e-04 | 5 | 78 | 2 | IPR020436 | |
| Domain | IQ | 2.21e-04 | 71 | 78 | 4 | PF00612 | |
| Domain | IQ | 3.67e-04 | 81 | 78 | 4 | SM00015 | |
| Domain | Somatomedin_B | 4.74e-04 | 8 | 78 | 2 | PF01033 | |
| Domain | SO | 6.08e-04 | 9 | 78 | 2 | SM00201 | |
| Domain | SET | 6.66e-04 | 41 | 78 | 3 | PF00856 | |
| Domain | Somatomedin_B_dom | 7.58e-04 | 10 | 78 | 2 | IPR001212 | |
| Domain | SMB_1 | 7.58e-04 | 10 | 78 | 2 | PS00524 | |
| Domain | SMB_2 | 7.58e-04 | 10 | 78 | 2 | PS50958 | |
| Domain | SET | 9.35e-04 | 46 | 78 | 3 | SM00317 | |
| Domain | SET_dom | 1.19e-03 | 50 | 78 | 3 | IPR001214 | |
| Domain | SET | 1.19e-03 | 50 | 78 | 3 | PS50280 | |
| Domain | Carboxylesterase_B_CS | 1.30e-03 | 13 | 78 | 2 | IPR019819 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.52e-03 | 14 | 78 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.52e-03 | 14 | 78 | 2 | IPR024743 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.52e-03 | 14 | 78 | 2 | PS00941 | |
| Domain | Dynein_heavy_dom-2 | 1.52e-03 | 14 | 78 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.52e-03 | 14 | 78 | 2 | PF08393 | |
| Domain | MT | 1.52e-03 | 14 | 78 | 2 | PF12777 | |
| Domain | AAA_8 | 1.52e-03 | 14 | 78 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.52e-03 | 14 | 78 | 2 | IPR011704 | |
| Domain | COesterase | 1.52e-03 | 14 | 78 | 2 | PF00135 | |
| Domain | CarbesteraseB | 1.52e-03 | 14 | 78 | 2 | IPR002018 | |
| Domain | AAA_5 | 1.52e-03 | 14 | 78 | 2 | PF07728 | |
| Domain | DHC_fam | 1.75e-03 | 15 | 78 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.75e-03 | 15 | 78 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.75e-03 | 15 | 78 | 2 | PF03028 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 1985022 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.21e-07 | 5 | 81 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.21e-07 | 5 | 81 | 3 | 12919077 | |
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.42e-07 | 6 | 81 | 3 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 2.42e-07 | 6 | 81 | 3 | 10588881 | |
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 35210422 | ||
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 16819597 | ||
| Pubmed | 6.76e-07 | 8 | 81 | 3 | 3864153 | ||
| Pubmed | 1.44e-06 | 10 | 81 | 3 | 19506036 | ||
| Pubmed | 1.98e-06 | 11 | 81 | 3 | 8136524 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 3.42e-06 | 13 | 81 | 3 | 8404542 | |
| Pubmed | 4.22e-06 | 102 | 81 | 5 | 10231032 | ||
| Pubmed | 4.35e-06 | 14 | 81 | 3 | 27184118 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18434543 | ||
| Pubmed | Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome. | 5.36e-06 | 2 | 81 | 2 | 8518795 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23183221 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 5.36e-06 | 2 | 81 | 2 | 37001827 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 5.36e-06 | 2 | 81 | 2 | 37080762 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 5.36e-06 | 2 | 81 | 2 | 9382868 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11150240 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 29106499 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 5.36e-06 | 2 | 81 | 2 | 24104404 | |
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 5.36e-06 | 2 | 81 | 2 | 32243781 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22989184 | ||
| Pubmed | Postnatal expression of Cdkl2 in mouse brain revealed by LacZ inserted into the Cdkl2 locus. | 5.36e-06 | 2 | 81 | 2 | 14605869 | |
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 5.36e-06 | 2 | 81 | 2 | 11744674 | |
| Pubmed | Somatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomas. | 5.36e-06 | 2 | 81 | 2 | 26841698 | |
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 5.50e-06 | 189 | 81 | 6 | 29449217 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.60e-05 | 3 | 81 | 2 | 26059207 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 36515178 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 32011705 | ||
| Pubmed | Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch. | 1.60e-05 | 3 | 81 | 2 | 26771232 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18628683 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 15082755 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10666376 | ||
| Pubmed | Vascular collagens: spotlight on the role of type VIII collagen in atherogenesis. | 1.60e-05 | 3 | 81 | 2 | 12482545 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 25405615 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 1.60e-05 | 3 | 81 | 2 | 21282647 | |
| Pubmed | Megalin interacts with APP and the intracellular adapter protein FE65 in neurons. | 1.60e-05 | 3 | 81 | 2 | 20637285 | |
| Pubmed | 1.82e-05 | 22 | 81 | 3 | 24301466 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 18495928 | ||
| Pubmed | Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity. | 3.20e-05 | 4 | 81 | 2 | 19789387 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 10388558 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 36618345 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 3.20e-05 | 4 | 81 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 3.20e-05 | 4 | 81 | 2 | 22671294 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 20579107 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 20357587 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 11023856 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 16077734 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 3.20e-05 | 4 | 81 | 2 | 11029314 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 17292328 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 3.20e-05 | 4 | 81 | 2 | 18417546 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 12547197 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 11175280 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 26320581 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 5.33e-05 | 5 | 81 | 2 | 30737693 | |
| Pubmed | Poly(A) tail length regulates PABPC1 expression to tune translation in the heart. | 5.33e-05 | 5 | 81 | 2 | 28653618 | |
| Pubmed | Dissecting KMT2D missense mutations in Kabuki syndrome patients. | 5.33e-05 | 5 | 81 | 2 | 30107592 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 18026121 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 24491801 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 5.33e-05 | 5 | 81 | 2 | 18923512 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 5.33e-05 | 5 | 81 | 2 | 10996085 | |
| Pubmed | Identification of the MLL2 complex as a coactivator for estrogen receptor alpha. | 5.33e-05 | 5 | 81 | 2 | 16603732 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 37865312 | ||
| Pubmed | 5.58e-05 | 418 | 81 | 7 | 34709266 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 6.31e-05 | 33 | 81 | 3 | 32094117 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 21838267 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 29724786 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 9837937 | ||
| Pubmed | CHARGE and Kabuki syndromes: a phenotypic and molecular link. | 7.99e-05 | 6 | 81 | 2 | 24705355 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 20417199 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 34622503 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 7.99e-05 | 6 | 81 | 2 | 17559643 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 8896557 | ||
| Pubmed | 1.05e-04 | 39 | 81 | 3 | 38690566 | ||
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 10075840 | ||
| Pubmed | FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. | 1.12e-04 | 7 | 81 | 2 | 19343227 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 30604749 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.12e-04 | 7 | 81 | 2 | 29758057 | |
| Pubmed | Regulation of transcription by the MLL2 complex and MLL complex-associated AKAP95. | 1.12e-04 | 7 | 81 | 2 | 23995757 | |
| Pubmed | 1.27e-04 | 331 | 81 | 6 | 29199018 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 26993635 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 1.49e-04 | 8 | 81 | 2 | 30871858 | |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 36200826 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 33667029 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 17178841 | ||
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 1.49e-04 | 8 | 81 | 2 | 22722839 | |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 15834955 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 1.49e-04 | 8 | 81 | 2 | 14667415 | |
| Pubmed | 1.53e-04 | 844 | 81 | 9 | 25963833 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 1.72e-04 | 46 | 81 | 3 | 28827394 | |
| Pubmed | 1.78e-04 | 504 | 81 | 7 | 34432599 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 23010509 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 31960486 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 22665483 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.79e-04 | 346 | 81 | 5 | chr17p13 | |
| Cytoband | 17p13.1 | 1.22e-03 | 118 | 81 | 3 | 17p13.1 | |
| Cytoband | 4q21.1 | 1.97e-03 | 37 | 81 | 2 | 4q21.1 | |
| GeneFamily | Myosin heavy chains | 1.70e-05 | 15 | 62 | 3 | 1098 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | COL8A1 CELSR1 NLGN4X DCDC1 PRCP NLGN4Y LRP2 GRID2 LIMCH1 CFAP210 DNAH6 | 2.35e-06 | 600 | 81 | 11 | M39055 |
| Coexpression | GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN | 2.92e-06 | 200 | 81 | 7 | M4116 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 3.12e-05 | 20 | 81 | 3 | M1123 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP | 3.30e-05 | 196 | 81 | 6 | M8503 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 3.63e-05 | 21 | 81 | 3 | MM1102 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.44e-09 | 193 | 81 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.60e-08 | 194 | 81 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 7.08e-08 | 196 | 81 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 7.08e-08 | 196 | 81 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 7.08e-08 | 196 | 81 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 3.41e-07 | 151 | 81 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.54e-07 | 164 | 81 | 6 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.57e-07 | 173 | 81 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.65e-07 | 177 | 81 | 6 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 9.86e-07 | 181 | 81 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.02e-06 | 182 | 81 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 184 | 81 | 6 | 42cadfdb5d29a50bd7e901ddd14d42b39e8474f0 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-06 | 184 | 81 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.12e-06 | 185 | 81 | 6 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.12e-06 | 185 | 81 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-06 | 186 | 81 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.19e-06 | 187 | 81 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.23e-06 | 188 | 81 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.23e-06 | 188 | 81 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-06 | 188 | 81 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 189 | 81 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-06 | 189 | 81 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.27e-06 | 189 | 81 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 189 | 81 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.27e-06 | 189 | 81 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.35e-06 | 191 | 81 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-06 | 191 | 81 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.35e-06 | 191 | 81 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-06 | 191 | 81 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.35e-06 | 191 | 81 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-06 | 191 | 81 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-06 | 191 | 81 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-06 | 191 | 81 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.39e-06 | 192 | 81 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-06 | 193 | 81 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.43e-06 | 193 | 81 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.43e-06 | 193 | 81 | 6 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.43e-06 | 193 | 81 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.48e-06 | 194 | 81 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.48e-06 | 194 | 81 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.48e-06 | 194 | 81 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.52e-06 | 195 | 81 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.52e-06 | 195 | 81 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.52e-06 | 195 | 81 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.52e-06 | 195 | 81 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-06 | 197 | 81 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-06 | 197 | 81 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 199 | 81 | 6 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 199 | 81 | 6 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.76e-06 | 200 | 81 | 6 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 200 | 81 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 200 | 81 | 6 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.76e-06 | 200 | 81 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.76e-06 | 200 | 81 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-06 | 200 | 81 | 6 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.76e-06 | 200 | 81 | 6 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.76e-06 | 200 | 81 | 6 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 200 | 81 | 6 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.76e-06 | 200 | 81 | 6 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-06 | 200 | 81 | 6 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-06 | 200 | 81 | 6 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-06 | 200 | 81 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Tshz2-Syt2_(Layer_5a,_Entorhinal_cortex,_Tshz1+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.28e-06 | 51 | 81 | 4 | adc73d6909d75ad432aef884dae540b7e48cecd6 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.24e-05 | 164 | 81 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-05 | 167 | 81 | 5 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 168 | 81 | 5 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 168 | 81 | 5 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 169 | 81 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 169 | 81 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | URO-Lymphocyte-B-B_intermediate|URO / Disease, Lineage and Cell Type | 1.47e-05 | 170 | 81 | 5 | e11d1510518cedabeece96d4adbb90999e6326fa | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.53e-05 | 82 | 81 | 4 | 47b131333ab84b70d2abe3fc17e63de504214b1b | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.56e-05 | 172 | 81 | 5 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.65e-05 | 174 | 81 | 5 | c8cec89369cf3896c5626e447051e76a142cb6df | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-05 | 178 | 81 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-05 | 178 | 81 | 5 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 81 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.99e-05 | 181 | 81 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.05e-05 | 182 | 81 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 182 | 81 | 5 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 182 | 81 | 5 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-05 | 183 | 81 | 5 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-05 | 183 | 81 | 5 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 185 | 81 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.21e-05 | 185 | 81 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.21e-05 | 185 | 81 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.27e-05 | 186 | 81 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-05 | 187 | 81 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.39e-05 | 188 | 81 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-05 | 188 | 81 | 5 | e82104f71bcdab7392fdb076dc3560255964fd9e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.45e-05 | 189 | 81 | 5 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 2.45e-05 | 189 | 81 | 5 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 81 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.45e-05 | 189 | 81 | 5 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 2.45e-05 | 189 | 81 | 5 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.45e-05 | 189 | 81 | 5 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.52e-05 | 190 | 81 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.52e-05 | 190 | 81 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 2.52e-05 | 190 | 81 | 5 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.52e-05 | 190 | 81 | 5 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-05 | 190 | 81 | 5 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.99e-06 | 12 | 79 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.99e-06 | 12 | 79 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.18e-06 | 13 | 79 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.21e-06 | 15 | 79 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.45e-05 | 80 | 79 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | GlcNAc sulfate conjugate of C21H34O2 steroid measurement | 1.05e-04 | 6 | 79 | 2 | EFO_0800663 | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 1.96e-04 | 8 | 79 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | myopathy (implicated_via_orthology) | 2.93e-04 | 48 | 79 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.83e-04 | 11 | 79 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.38e-04 | 55 | 79 | 3 | C0079744 | |
| Disease | Malignant neoplasm of breast | EHBP1 MYH1 KMT2D SPATA21 SPEN SLCO1B1 ANAPC5 PABPC1 PCDH8 VPS13B | 5.79e-04 | 1074 | 79 | 10 | C0006142 |
| Disease | Schizophrenia | 5.84e-04 | 883 | 79 | 9 | C0036341 | |
| Disease | superior frontal gyrus grey matter volume measurement | 6.31e-04 | 14 | 79 | 2 | EFO_0006516 | |
| Disease | magnesium measurement | 7.49e-04 | 66 | 79 | 3 | EFO_0004845 | |
| Disease | congenital heart disease (implicated_via_orthology) | 8.52e-04 | 69 | 79 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 9.26e-04 | 71 | 79 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | asparaginase hypersensitivity | 1.17e-03 | 77 | 79 | 3 | EFO_0004881 | |
| Disease | diet measurement, body mass index | 1.30e-03 | 20 | 79 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 2.21e-03 | 26 | 79 | 2 | EFO_0007870 | |
| Disease | optic disc size measurement | 2.26e-03 | 205 | 79 | 4 | EFO_0004832 | |
| Disease | vascular endothelial function measurement | 2.41e-03 | 99 | 79 | 3 | EFO_0803369 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKYAGLQPYLDQINV | 96 | Q6QNY1 | |
| GPKLYQHYQQQQQVA | 146 | Q7RTS1 | |
| YGIVAFAQNSLYKQV | 3651 | Q8WXG9 | |
| IPQQVVGYFNTYKLL | 511 | O75131 | |
| QNLPADGFKYNYVFA | 3511 | Q86UQ4 | |
| VFPKQFKTQQYYNVL | 176 | Q96CM8 | |
| KNELVQKFQVYYLGN | 536 | O00213 | |
| QKFQVYYLGNVPVAK | 541 | O00213 | |
| YPIYSNLVPFTKNNN | 176 | P32238 | |
| QVQYYNKPNIGHLGL | 1531 | Q9NYQ6 | |
| FCQGNQLNYYKQEIP | 1196 | Q9UPY3 | |
| PYDQLQIYANGKNIG | 251 | P00736 | |
| QYQASGLNNVPYSAK | 91 | Q07687 | |
| QLLFQVTNPGIKYEY | 796 | P58397 | |
| IIFYKNGVNQGVAYK | 541 | Q9UBL3 | |
| FKILQEYQVQYTPQG | 636 | O94925 | |
| YKYAAGVRNPQQHLN | 511 | P11940 | |
| VFKLYTALQQYFQNG | 151 | Q9UJX4 | |
| GLQKIFSAVQQFYQP | 911 | Q9NVI1 | |
| YLYLQNNKISAVPAN | 526 | Q7Z5L7 | |
| VIVQKYKPYNNGAAN | 1246 | M0R2J8 | |
| AKQQLQTQGYRQTPY | 136 | Q68CZ1 | |
| QQYELKVACGNNPVY | 4056 | Q5CZC0 | |
| VFFGLTQPKYQYVLN | 91 | A6PVY3 | |
| QAGIQKVKYGNYAFV | 726 | O43424 | |
| QQVYNAVGALAKAVY | 421 | P13535 | |
| KPNYTALGCQQYTQF | 156 | Q32ZL2 | |
| SYVHKQYPANQGQEV | 76 | O43660 | |
| VQYYKKIIIANGFPN | 491 | Q6UWM7 | |
| DNYYQAQLPKTVGLQ | 1001 | O95206 | |
| KPTYAAFINLLNNYQ | 196 | P21128 | |
| LPAVAKNYSVLYFQQ | 41 | P42785 | |
| QQVYNAVGALAKAVY | 421 | P12882 | |
| KANKFTETNPQVYYQ | 626 | P98164 | |
| YFINNKQDGESYKNP | 271 | Q9BX67 | |
| YANNPRVVFNLNTYK | 216 | P17301 | |
| AYNNYIIKGNLFEPV | 571 | Q6ZMV5 | |
| PYQPKSFQQKRNYFQ | 961 | Q96JP2 | |
| VYQNNVLPLYKSVQA | 286 | O15488 | |
| SQAQYPVVNTNYGKI | 41 | Q8NFZ3 | |
| NGLDYQVVQKYLFQI | 96 | Q92772 | |
| NKIQESAGYVPVYLN | 2111 | Q9C0G6 | |
| VPDQIINFYKSNYVQ | 1426 | Q92608 | |
| FQKNQVGPCKYLNVY | 596 | Q8TD57 | |
| IAYQYGKNVGIAFQL | 291 | Q5T2R2 | |
| IQVQDVAPPYYKNNV | 431 | Q6ZTQ4 | |
| YNIVPFEAGQYFNKI | 201 | Q9Y6N1 | |
| QLKVNLQPNDNYFFY | 3861 | Q8N3K9 | |
| NKLLYNGRQNYNPQT | 636 | P27658 | |
| NSYNPFKEVQTPQYL | 306 | Q8NDI1 | |
| SQAQYPVVNTNYGKI | 41 | Q8N0W4 | |
| FNQYLPNKSNQTAYV | 266 | Q9UPQ0 | |
| YFGPDVTQQLLQKYN | 466 | O14830 | |
| QFDYGVYLLNKNIAQ | 421 | Q9P2Y5 | |
| VNAFPAQNNYGLYDL | 216 | Q8NBJ7 | |
| GKYENNYNAVFNLLP | 416 | Q8IYR2 | |
| YPTKFQYLNFANNIL | 346 | Q9BXR5 | |
| LKQQNYAPNLQSPYA | 386 | Q7Z572 | |
| ANIVNLNKQVYGPFY | 481 | Q8N4U5 | |
| GLFNQYISQQEYKPR | 236 | Q9UL63 | |
| IYNTQGFKEPNIQTY | 61 | Q13393 | |
| QYGFNYNKFLKNGIP | 106 | Q8NA58 | |
| QQVYNAVGALAKAIY | 421 | Q9Y623 | |
| NIYFYTIKPIPANQE | 181 | O75626 | |
| PILQQYYNTKQAVCF | 251 | P49221 | |
| GSIQQYIYKQEPVQK | 1266 | Q92954 | |
| KYVEQQYGQPSSKAN | 361 | Q9Y6L6 | |
| PQLTGGTLYKYNNFQ | 651 | O94855 | |
| IYKQYAPVAYQNQVE | 1626 | Q8NFU7 | |
| GVQLPFYNSQGPKYN | 526 | Q0VFZ6 | |
| VLHPFYRSNNQVYQK | 66 | Q32M92 | |
| KVNGVPQYAFLQYCD | 471 | Q96T58 | |
| LIYGQVAPNANYNDV | 96 | Q9UNG2 | |
| YQEAFQKLQNIKYPS | 1176 | Q8TEQ6 | |
| NYAYNGNINIPNAEV | 1386 | O00507 | |
| IPGSDYINANYIKNQ | 296 | P29350 | |
| YINANYIKNQLLGPD | 301 | P29350 | |
| QFKVAMNYLQLYNVP | 96 | Q9Y2K1 | |
| KYVNVFYKFSNPNIQ | 181 | Q9H8G1 | |
| IINNTPYQIFYKPQL | 3111 | Q7Z7G8 | |
| YEQQGIDYAQFLPKI | 1366 | P35125 | |
| VQLYRQNNKLYGSVF | 226 | Q6ZSZ6 | |
| VLYANINFPNLKQDY | 2021 | O14686 |